Seven-year (yr) follow-up of adjuvant paclitaxel (T) and trastuzumab (H) (APT trial) for node-negative, HER2-positive breast cancer (BC) Meeting Abstract
| Authors: | Tolaney, S. M.; Barry, W. T.; Guo, H.; Dillon, D.; Dang, C. T.; Yardley, D. A.; Moy, B.; Marcom, P. K.; Albain, K. S.; Rugo, H. S.; Ellis, M. J.; Shapira, I.; Wolff, A. C.; Carey, L. A.; Overmoyer, B.; Partridge, A. H.; Hudis, C. A.; Krop, I. E.; Burstein, H. J.; Winer, E. P. |
| Abstract Title: | Seven-year (yr) follow-up of adjuvant paclitaxel (T) and trastuzumab (H) (APT trial) for node-negative, HER2-positive breast cancer (BC) |
| Meeting Title: | 53rd Annual Meeting of the American Society of Clinical Oncology (ASCO) |
| Journal Title: | Journal of Clinical Oncology |
| Volume: | 35 |
| Issue: | 15 Suppl. |
| Meeting Dates: | 2017 Jun 2-6 |
| Meeting Location: | Chicago, IL |
| ISSN: | 0732-183X |
| Publisher: | American Society of Clinical Oncology |
| Date Published: | 2017-05-20 |
| Start Page: | 11s |
| Language: | English |
| ACCESSION: | WOS:000411895700029 |
| DOI: | 10.1200/JCO.2017.35.15_suppl.511 |
| PROVIDER: | wos |
| Notes: | Meeting Abstract: 511 -- Source: Wos |
Altmetric
Citation Impact
BMJ Impact Analytics
